RETRACTED ARTICLE: Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone
- 17 October 2017
- journal article
- retracted article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 184 (4) , 1390-1403
Abstract
Chronic kidney disease may lead to subsequent tissue fibrosis. However, many factors can combat injurious stimuli in these tissues aiming to repair, heal, and alleviate any disturbance. Chemokines release, migration of inflammatory cells to the affected site, and activation of fibroblasts for the production of extracellular matrix are commonly observed in this disease. In the last years, many studies have focused on spironolactone (SPL), a mineralocorticoid receptor antagonist, and its pharmacological effects. In the present study, SPL was selected as an anti-inflammatory agent to combat nephrotoxicity and renal fibrosis induced by cisplatin. Mesenchymal stem cells (MSCs) were also selected in addition as a referring agent. Renal fibrosis induced by cisplatin intake significantly increased creatinine, urea, nuclear factor kappa B, insulin-like growth factor-1, fibroblast growth factor-23, and kidney malondialdehyde (MDA) content. Hepatocyte growth factor and renal content of reduced glutathione demonstrated a significant decrease. Histopathological examination of kidney tissues demonstrated marked cellular changes which are correlated with the biochemical results. Oral SPL intake (20 mg/kg/body weight) daily for 4 weeks and MSCs administration (3 × 106 cell/rat) intravenous to the experimental rats resulted in a significant improvement of both the biomarkers studied and the histopathological profile of the renal tissue. Individual administration of spironolactone and MSCs exhibited a marked anti-inflammatory potential and alleviated to a great extent the nephrotoxicity and renal fibrotic pattern induced by cisplatin.Keywords
This publication has 71 references indexed in Scilit:
- An integrative view of the pathophysiological events leading to cisplatin nephrotoxicityCritical Reviews in Toxicology, 2011
- Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic MiceTransplantation and Cellular Therapy, 2009
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney diseasePediatric Nephrology, 2008
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid miceProceedings of the National Academy of Sciences, 2006
- Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db miceBiochemical and Biophysical Research Communications, 2003
- Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cellsKidney International, 1998
- Hepatocyte Growth Factor Protects Renal Epithelial Cells from Apoptotic Cell DeathBiochemical and Biophysical Research Communications, 1998
- Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertensionThe American Journal of Cardiology, 1993